Robbins LLP is Investigating Allegations that Bitdeer Technologies Group (BTDR) Misled Investors Regarding its Business Prospects SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Bitdeer Technologies Group (NASDAQ: BTDR) securities between June 6, 2024 and November 10, 2025. Bitdeer is a Bitcoin mining and high-performance computing (HPC) data-center infrastructure company with locations in Singapore, th ...

Core Viewpoint - A class action lawsuit has been filed against Sprouts Farmers Market, Inc. for allegedly misleading investors about its growth potential during the class period from June 4, 2025, to October 29, 2025 [1][3]. Allegations - The complaint claims that the defendants provided investors with optimistic information regarding Sprouts' growth potential for fiscal year 2025, asserting confidence in the customer base's resilience to macroeconomic pressures [3]. - It is alleged that the defendants concealed significant adverse facts about Sprouts' actual growth potential, particularly that a more cautious consumer could lead to a notable slowdown in sales growth, undermining the expected benefits from a cautious consumer environment [3]. Financial Performance - On October 29, 2025, Sprouts reported disappointing third-quarter results for fiscal 2025, with comparable store growth falling below expectations [4]. - The company also issued disappointing guidance for the fourth quarter and reduced its full-year estimates, attributing these results to "challenging year-on-year comparisons" and signs of a softening consumer [4]. - Following this announcement, Sprouts' stock price plummeted from $104.55 per share on October 29, 2025, to $77.25 per share on October 30, 2025, marking a decline of approximately 26.11% [4].

Core Points - A class action has been filed against Integer Holdings Corporation (ITGR) on behalf of investors who acquired its securities between July 25, 2024, and October 22, 2025, alleging misleading information regarding the company's market position and product demand [1][2] - The complaint claims that Integer Holdings overstated the demand for its electrophysiology (EP) devices, while in reality, demand had significantly decreased, contradicting the company's claims of outpacing market growth [2] - On October 23, 2025, Integer revised its full-year 2025 guidance, expecting net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, leading to a stock price drop of over 32% [3] Allegations and Impact - The allegations suggest that Integer Holdings misled investors about the demand for its EP devices, which has been declining rather than growing as claimed [2] - The company's admission of slower market adoption for two of its EP devices has raised concerns about continued demand issues into 2026 [3] - Following the announcement of revised guidance, Integer's stock fell by $35.22 per share, closing at $73.89 on October 23, 2025, indicating a significant loss in investor confidence [3] Legal Proceedings - Shareholders interested in participating in the class action must submit their papers by February 9, 2026, to serve as lead plaintiff, representing the interests of other class members [4] - Shareholders are not required to participate in the case to be eligible for recovery, allowing them to remain absent class members if they choose [4]

All representation is on a contingency fee basis. Shareholders pay no fees or expenses. NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Integer Holdings Corporation (NYSE: ITGR) common stock between July 25, 2024 and October 22, 2025, both dates inclusive (the "Class Period†). Integer is a medical device contract manufacturer. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-7 ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Bitdeer Technologies Group (NASDAQ: BTDR) securities between June 6, 2024 and November 10, 2025, both dates inclusive (the "Class Period†). Bitdeer is a bitcoin mining and high-performance computing (HPC) data-center infrastructure company. What Now: You may be eligible to participate in the class action against Bitdeer Technologies Group. Shareholders who ...

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit against Gauzy Ltd. for allegedly misleading investors regarding its business operations and financial stability [1][2]. Group 1: Allegations - The lawsuit claims that Gauzy's French subsidiaries lacked the financial means to meet their debts as they became due [3]. - It is alleged that insolvency proceedings were likely to commence due to the financial issues faced by these subsidiaries [3]. - The lawsuit also states that a potential default under Gauzy's existing senior secured debt facilities was substantially likely as a result of these issues [3]. - Positive statements made by Gauzy regarding its business operations and prospects were deemed materially misleading and lacked a reasonable basis [3]. Group 2: Legal Proceedings - Shareholders wishing to serve as lead plaintiffs must file their motions with the court by February 6, 2026 [4]. - Participation in the class action is not required to be eligible for recovery; shareholders can remain absent class members if they choose [4]. Group 3: Rosen Law Firm Background - Rosen Law Firm is recognized for its commitment to shareholder rights litigation and has recovered over $1 billion for shareholders since its inception [6].

Core Points - Class actions have been initiated on behalf of stockholders of DexCom, Inc. and CarMax, Inc. with specific deadlines for investors to petition the court to serve as lead plaintiff [1] DexCom, Inc. (NASDAQ:DXCM) - The class period for DexCom is from January 8, 2024, to September 17, 2025, with a lead plaintiff deadline of December 26, 2025 [6] - The complaint alleges that DexCom made materially false and misleading statements regarding its business and compliance policies, including unauthorized design changes to the G6 and G7 devices that compromised their reliability and posed health risks to users [6] - The lawsuit claims that these misstatements subjected DexCom to increased regulatory scrutiny and potential legal and financial harm [6] CarMax, Inc. (NYSE:KMX) - The class period for CarMax is from June 20, 2025, to September 24, 2025, with a lead plaintiff deadline of January 2, 2026 [6] - The lawsuit alleges that CarMax's defendants overstated growth prospects, attributing earlier growth to temporary factors related to customer behavior influenced by tariff speculation [6] - As a result, the statements made by CarMax's defendants regarding the company's business and operations were deemed materially false and misleading [6]

Core Viewpoint - StubHub Holdings, Inc. is facing a class action lawsuit due to allegedly false statements made during its September 2025 IPO, which misled investors regarding the company's financial health and cash flow situation [3][4]. Company Overview - StubHub Holdings, Inc. operates a global ticketing marketplace for live events through its StubHub and viagogo platforms [1]. Class Action Details - The class action includes shareholders who purchased StubHub common stock linked to the IPO registration statement [2]. - The lawsuit claims that the registration statement was materially false and misleading, omitting critical information about changes in vendor payment timing and its adverse effects on free cash flow [4]. Financial Performance - On November 13, 2025, StubHub reported disappointing Q3 2025 financial results, revealing a free cash flow of negative $4.6 million, a 143% decrease from the previous year's positive $10.6 million [5]. - The company's net cash provided by operating activities fell to $3.8 million, a 69.3% decrease from $12.4 million in the same period last year [5]. - Following the financial announcement, StubHub's stock price dropped by $3.95 per share, or 20.9%, closing at $14.87 on November 14, 2025, and later trading as low as $10.31, nearly a 56% decline from the IPO price of $23.50 [6]. Legal Actions - Shareholders interested in participating as lead plaintiffs in the class action must file their papers by January 23, 2026 [7].

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corporation, alleging that the company made false and misleading statements regarding its merger with Cedar Fair, L.P. and the financial health of Legacy Six Flags prior to the merger [1][3]. Group 1: Merger Details - The merger between Legacy Six Flags and Cedar Fair was approved by shareholders on March 12, 2024, and officially closed on July 1, 2024 [3]. - Following the merger, the new entity was named CopperSteel HoldCo, Inc., which later changed its name to Six Flags and began trading on the NYSE under the ticker symbol "FUN" [3]. Group 2: Allegations - The lawsuit claims that Legacy Six Flags had significantly underinvested in its parks and operations, neglecting essential maintenance and improvements for several years before the merger [3]. - It is alleged that Legacy Six Flags required millions of dollars in undisclosed capital and operational expenditures to maintain or grow its market share in the competitive amusement park industry [3]. - The complaint states that the financial projections presented to investors were unrealistic and not based on the actual conditions of the company at the time of the merger [3]. Group 3: Stock Performance - On the merger closing date, Six Flags stock was trading above $55 per share, but it subsequently plummeted to as low as $20 per share, representing a nearly 64% decline [4].

Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit due to alleged misleading statements regarding the launch and performance of its Inspire V Device, which has resulted in significant financial losses for investors [1][3][5]. Company Overview - Inspire Medical Systems, Inc. is a medical technology company that develops and manufactures an implantable device for treating obstructive sleep apnea, known as the Inspire V Device [1][3]. Allegations and Issues - The lawsuit claims that the company misled investors about the Inspire V Device's launch, which was described as groundbreaking but ultimately faced poor demand and significant operational failures [3][4]. - Key failures included inadequate training for treatment centers, lack of essential IT systems, and unpreparedness for insurance claims processing, which were critical for a successful product launch [4]. Financial Impact - On August 4, 2025, the company announced a drastic reduction in its 2025 earnings guidance by over 80%, leading to a stock price drop of $42.04 per share (over 32%) in one day, erasing $1.2 billion in market capitalization [5]. - From a high of $216.71 per share on September 23, 2024, the stock price plummeted by $127.00 per share (nearly 60%), resulting in billions of dollars lost in market capitalization [5].